CDER Adds Gaucher Disease to 2017 Guidance Agenda Post author:Sam Post published:April 20, 2017 Post category:Drug Industry Daily CDER updated its guidance agenda for 2017, adding an item on Gaucher Disease. Source: Drug Industry Daily You Might Also Like Despite Summer Launch, Questions Remain About FDA’s Inspectional Affairs Council November 17, 2021 Eisai 483 Handed Form 483 after Investigators Cite Control Records, CAPA Procedures January 20, 2017 EMA Issues Q&A on Health-Based Exposure Limits and Prevention of Cross-Contamination April 30, 2018
